EKF Diagnostics Holdings plc (LON:EKF – Get Free Report)’s share price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 25.66 and traded as low as GBX 25.20. EKF Diagnostics shares last traded at GBX 26, with a volume of 46,083 shares changing hands.
Analysts Set New Price Targets
Separately, Stifel Nicolaus reiterated a “buy” rating and issued a GBX 35 price objective on shares of EKF Diagnostics in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of GBX 35.
Check Out Our Latest Analysis on EKF Diagnostics
EKF Diagnostics Price Performance
About EKF Diagnostics
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
- Five stocks we like better than EKF Diagnostics
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
